What these medications do not do Mounjaro and Ozempic do not replace the basics of long-term health
Our bioactive LR3 IGF-IHuman, E
GLP-1R agonists (GLP-1RAs) have many functions, such as neuroprotection, inhibiting infection, and metabolic regulation, and show good application prospects in improving cognitive function
Some even go as far to say that, not only will incremental volumes be lower (as a more significant percentage will be won by orals) but also that orals will cannibalize the existing injectable volumes (so not only not a tailwind to future volumes, but also a headwind to existing volumes)
Senior Scientist II, Pipeline Development, Global Biologics, USP Mr
Timeline: noticeable regain begins within 24 weeks as appetite returns